[NOAH HOLDINGS LIMITED Tao Thomas Wu Chief Financial Officer Noah Holdings Limited to Hold 2011 Annual General Meeting on November 3, 2011 Shanghai, September 22, 2011 No proposal will be submitted for shareholder approval at the annual general meeting. Instead, the annual general meeting will serve as an open forum for shareholders and beneficial owners of the Companys American Depositary]
[NOAH HOLDINGS LIMITED Tao Thomas Wu Chief Financial Officer Noah Holdings Limited to Hold 2011 Annual General Meeting on November 3, 2011 Shanghai, September 22, 2011 No proposal will be submitted for shareholder approval at the annual general meeting. Instead, the annual general meeting will serve as an open forum for shareholders and beneficial owners of the Companys American Depositary]
[SCHEDULE 14A x o Check the appropriate box: o o x o o Biostar Pharmaceuticals, Inc. _____________________________________ Payment of Filing Fee (Check the appropriate box): x o (1) Title of each class of securities to which transaction applies: ______________________________________ (2) Aggregate number of securities to which transaction applies: ______________________________________ (3) (4) Proposed maximum aggregate value of transaction: ______________________________________ (5) Total]
[SCHEDULE 14A x o Check the appropriate box: o o x o o Biostar Pharmaceuticals, Inc. _____________________________________ Payment of Filing Fee (Check the appropriate box): x o (1) Title of each class of securities to which transaction applies: ______________________________________ (2) Aggregate number of securities to which transaction applies: ______________________________________ (3) (4) Proposed maximum aggregate value of transaction: ______________________________________ (5) Total]
[China Pharma Holdings, Inc. Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 September 23, 2011 VIA EDGAR Ms. Tabatha Akins Staff Accountant Division of Corporation Finance 100 F Street, NE Re: China Pharma Holdings, Inc. Form 10-K for the fiscal year ended December 31, 2010 Filed March 3, 2011 and Amended March 17, 2011 Form 10-Q for]
[China Pharma Holdings, Inc. Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 September 23, 2011 VIA EDGAR Ms. Tabatha Akins Staff Accountant Division of Corporation Finance 100 F Street, NE Re: China Pharma Holdings, Inc. Form 10-K for the fiscal year ended December 31, 2010 Filed March 3, 2011 and Amended March 17, 2011 Form 10-Q for]
[China Pharmas, Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 September 23, 2011 VIA EDGAR Ms. Tabatha Akins Staff Accountant Division ofrporation Finance 100 F Street, NE Re: China Pharmas, Form 10-K for the fiscal year ended December 31, 2010 Filed March 3, 2011 and Amended March 17, 2011]
[LETTER TO SHAREHOLDERS IS AVAILABLE ON SINOCOKING’S WEBSITE PINGDINGSHAN, China – September 23, 2011 - SinoCoking Coal and Coke Chemical Industries, Inc. (Nasdaq:SCOK) (the "Company" or "SinoCoking"), The letter includes a point-by-point response to assertions made by a disclosed short-seller in a blog report published on September 20, 2011. The Company believes that this letter will provide its shareholders with] [Item 8.01 Other Events. Number Description]
[LETTER TO SHAREHOLDERS IS AVAILABLE ON SINOCOKING’S WEBSITE PINGDINGSHAN, China – September 23, 2011 - SinoCoking Coal and Coke Chemical Industries, Inc. (Nasdaq:SCOK) (the "Company" or "SinoCoking"), The letter includes a point-by-point response to assertions made by a disclosed short-seller in a blog report published on September 20, 2011. The Company believes that this letter will provide its shareholders with] [Item 8.01 Other Events. Number Description]
